First-pass extracted concept

logical combination treatments

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

special attention is paid to logical combination treatments, which include combining targeted medicines with ICIs, irradiation, or synthetic lethality techniques.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1emerging targetssupports2025Source 1DOI PubMed

FGFR4, AXL, and c-MET are presented as new targets in hepatocellular carcinoma targeted therapy.

Claim 2mechanistic relevancesupports2025Source 1DOI PubMed

The tumor microenvironment, epigenetic regulators including EZH2 and HDACs, and oncogenic signaling pathways including Wnt/β-catenin, PI3K/AKT/mTOR, and RAS/RAF/MEK/ERK are relevant to targeted therapeutics for hepatocellular carcinoma.

Claim 3strategy recommendationsupports2025Source 1DOI PubMed

Rational combination treatments that pair targeted medicines with immune checkpoint inhibitors, irradiation, or synthetic lethality techniques are emphasized as strategies to overcome resistance mechanisms and improve therapeutic effectiveness in hepatocellular carcinoma.